Editas Medicine (EDIT) Market Capitalization (2016 - 2025)
Powered by 
Analysis
Editas Medicine (EDIT) Market Capitalization (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Editas Medicine | 287.84 Mn | 141.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 191.19 Mn |
| Sep 30, 2025 | 323.63 Mn |
| Jun 30, 2025 | 192.25 Mn |
| Mar 31, 2025 | 97.10 Mn |
| Dec 31, 2024 | 105.07 Mn |
| Sep 30, 2024 | 281.46 Mn |
| Jun 30, 2024 | 384.95 Mn |
| Mar 31, 2024 | 610.18 Mn |
| Dec 31, 2023 | 828.30 Mn |
| Sep 30, 2023 | 637.02 Mn |
| Jun 30, 2023 | 671.71 Mn |
| Mar 31, 2023 | 500.20 Mn |
| Dec 31, 2022 | 610.68 Mn |
| Sep 30, 2022 | 841.64 Mn |
| Jun 30, 2022 | 812.94 Mn |
| Mar 31, 2022 | 1.30 Bn |
| Dec 31, 2021 | 1.82 Bn |
| Sep 30, 2021 | 2.81 Bn |
| Jun 30, 2021 | 3.86 Bn |
| Mar 31, 2021 | 2.83 Bn |